These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 33324209)

  • 1. PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC.
    Wang X; Liang C; Yao X; Yang RH; Zhang ZS; Liu FY; Li WQ; Pei SH; Ma J; Xie SQ; Fang D
    Front Pharmacol; 2020; 11():577108. PubMed ID: 33324209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC.
    Wang X; Liang C; Yao X; Yang RH; Zhang ZS; Liu FY; Li WQ; Pei SH; Ma J; Xie SQ; Fang D
    Front Pharmacol; 2021; 12():724799. PubMed ID: 34335281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF promotes
    Niu J; Li W; Liang C; Wang X; Yao X; Yang RH; Zhang ZS; Liu HF; Liu FY; Pei SH; Li WQ; Sun H; Fang D; Xie SQ
    Sci Signal; 2020 Nov; 13(657):. PubMed ID: 33172955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P300-dependent acetylation of histone H3 is required for epidermal growth factor receptor-mediated high-mobility group protein A2 transcription in hepatocellular carcinoma.
    Liang C; Niu J; Wang X; Zhang ZS; Yang RH; Yao X; Liu FY; Li WQ; Pei SH; Sun H; Wang CJ; Fang D; Xie SQ
    Cancer Sci; 2021 Feb; 112(2):679-690. PubMed ID: 33164305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 8. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors.
    Palsson-McDermott EM; Dyck L; Zasłona Z; Menon D; McGettrick AF; Mills KHG; O'Neill LA
    Front Immunol; 2017; 8():1300. PubMed ID: 29081778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MAPK activity in PD-L1 expression in hepatocellular carcinoma cells.
    Xing S; Chen S; Yang X; Huang W
    J BUON; 2020; 25(4):1875-1882. PubMed ID: 33099927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.
    Yang W; Xia Y; Hawke D; Li X; Liang J; Xing D; Aldape K; Hunter T; Alfred Yung WK; Lu Z
    Cell; 2012 Aug; 150(4):685-96. PubMed ID: 22901803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
    Yang W; Xia Y; Ji H; Zheng Y; Liang J; Huang W; Gao X; Aldape K; Lu Z
    Nature; 2011 Dec; 480(7375):118-22. PubMed ID: 22056988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.
    Li TE; Wang S; Shen XT; Zhang Z; Chen M; Wang H; Zhu Y; Xu D; Hu BY; Wei R; Zheng Y; Dong QZ; Qin LX
    Front Immunol; 2020; 11():589997. PubMed ID: 33193421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
    Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
    J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment.
    Shrestha R; Prithviraj P; Bridle KR; Crawford DHG; Jayachandran A
    J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33925488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation.
    Fan FT; Shen CS; Tao L; Tian C; Liu ZG; Zhu ZJ; Liu YP; Pei CS; Wu HY; Zhang L; Wang AY; Zheng SZ; Huang SL; Lu Y
    Asian Pac J Cancer Prev; 2014; 15(5):1961-70. PubMed ID: 24716919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Ser28 in histone H3 mediated by mixed lineage kinase-like mitogen-activated protein triple kinase alpha.
    Choi HS; Choi BY; Cho YY; Zhu F; Bode AM; Dong Z
    J Biol Chem; 2005 Apr; 280(14):13545-53. PubMed ID: 15684425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65.
    Liu ZC; Ning F; Wang HF; Chen DY; Cai YN; Sheng HY; Lash GE; Liu L; Du J
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2568-2582. PubMed ID: 28844984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers.
    Cheng CC; Lin HC; Tsai KJ; Chiang YW; Lim KH; Chen CG; Su YW; Peng CL; Ho AS; Huang L; Chang YC; Lin HC; Chang J; Chang YF
    Mol Carcinog; 2018 Nov; 57(11):1588-1598. PubMed ID: 30035369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.